Resources

Simtra Biopharma Solutions Capacity Update October 2023: Biologics

Simtra BioPharma Solutions (Simtra) is a premier CMO with a singular focus on sterile injectable drug product form/fill/finish services.

Is Mannitol Hemihydrate Detrimental to Protein Stability Assessing Mannitol Crystallinity in Lyophilized Drug Products

Learn from the BioPharma Solutions team under what conditions MHH dehydrates and how the dehydration impacts protein stability.

Bloomington Virtual Tour Preview

Halle/Westfalen, Germany, Virtual Tour Preview

Vial Breakage During Lyophilization

Learn more from the BioPharma Solutions team on the Root Causes and Mitigation Strategy for Vial Breakage during Lyophilization.

Evolving With Our Customers

A Halle/Westfalen Program Manager's Perspective

Evolving With Our Customers

Previewing Our $100 Million Facility Expansion in Halle/Westfalen, Germany

Baxter Cyto/NonCyto

With the advent of more product niches and often lowered production quantities, facilities that are experienced and versatile in handling cytotoxic, highly potent, and non-cytotoxic oncology products can present a valid option.

BPS Awards

Bringing your Sterile Injectable Product to Market: Considerations for Collaborating with a Fill/Finish CMO

Bringing your Sterile Injectable Product to Market: Considerations for Collaborating with a Fill/Finish CMO - CMO Selection, Request for Proposal (RFP) Delivery, Proposal Review, and Project Award.

Simtra BioPharma Solutions’ Capabilities Overview

Baxter Biosimilars Case Study

This paper discusses important development considerations of a lyophilized biosimilar as well as providing an example/case study with outcome/results.